Neo Cremar Co (XKRX:311390) ROCE % : 1.21% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Neo Cremar Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Neo Cremar Co's annualized ROCE % for the quarter that ended in Dec. 2024 was 1.21%.

Neo Cremar Co ROCE % Historical Data

The historical data trend for Neo Cremar Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neo Cremar Co ROCE % Chart

Neo Cremar Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

3.38

4.20

-2.63

-11.63

1.28

Neo Cremar Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															18.62	-11.32	18.43	-3.78	1.21

Neo Cremar Co ROCE % Calculation

Neo Cremar Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	1273.913	/	( ( (71136.284 - 30672.899)	+	(178338.004 - 19477.92) )	/ 2 )
	=	1273.913	/	( (40463.385	+	158860.084)	/ 2 )
	=	1273.913	/	99661.7345
	=	1.28 %

Neo Cremar Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	1782.544	/	( ( (156099.311 - 21343.589)	+	(178338.004 - 19477.92) )	/ 2 )
	=	1782.544	/	( ( 134755.722	+	158860.084 )	/ 2 )
	=	1782.544	/	146807.903
	=	1.21 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Neo Cremar Co (XKRX:311390) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Neo Cremar Co ROCE % Related Terms

Thank you for viewing the detailed overview of Neo Cremar Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neo Cremar Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Neo Cremar Co Ltd (XKRX:311390) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Beobwon-ro, 11-gil, Songpa-gu, A-714, Hyundai Knowledge Center, Seoul, KOR, 05836

Website

http://www.cremar.co.kr

Neo Cremar Co Ltd is a South Korea based company engaged in supplying ingredients of functional foods. It is involved in the selling of products such as Galactooligosaccharide which has prebiotics effect and skin-improving effect and Palatinose which deters rise in blood sugar. Some of its other products include Neotide, Cyclodextrin syrup, Water-soluble curcumin, and Duoligo.

Neo Cremar Co Headlines

No Headlines